EIN 20-8735688

Solving Kids Cancer

IRS 501(c) type
501(c)(3)
Num. employees
5
Year formed
2006
Most recent tax filings
2022-12-01
NTEE code, primary
Description
Solving Kids Cancer initiates clinical trials for effective treatments, drives research advocacy, and targets areas of greatest unmet needs.
Total revenues
$894,267
2022
Total expenses
$1,209,405
2022
Total assets
$2,595,479
2022
Num. employees
5
2022

Program areas at Solving Kids Cancer

Skc and our advisors survey, actively discuss and prioritize the areas of greatest unmet needs within the pediatric Cancer research landscape and develop specific programs to address them. (1) the ph i titan clinical trial is providing an effective targeted drug for children with alk mutations in frontline treatment when newly diagnosed and is generating critical data towards an approval for use as a standard of care. Working towards having this be one of the first targeted agents becoming approved for hr nb and utilized as a combination therapy strategy, making a significant impact on overall survival. (2) our collaboration with the national Cancer institute (nci) to validate and develop an immunotherapy treatment for children with etmr brain tumors using a t-cell car to target (continued on sch o) gpc2 is the first-ever immunotherapy research program specific for etmr brain tumors. If the results are positive, this work will be rapidly translated to include children with etmr in a clinical trial using this cutting-edge immunotherapy. (3) the ph i clin trial using a triplet combination has been a lifeline for children with neuroblastoma who relapse and the study has been so successful that it will stay open to accrue even more patients than originally planned. While the clinical trial is providing treatment benefit to patients, the trial is generating very important data that can be used to further advance this triple treatment combination into more points in the treatment continuum for even greater patient benefit. (4) skc targets only the most challenging and poorest outcome childhood cancers that require significant help and have the greatest unmet need including high-risk brain tumors and solid tumors. (5) takes a global approach to supporting programs to leverage the collective power of collaboration across several centers-of-excellence to break down barriers, speed progress and have more children access promising treatments. (6) prioritizes advancing treatment options that have the highest potential for curative responses rather than partial tumor shrinkage or temporary life extension. (7) takes leadership roles within influential national and international research groups' advisory boards and co-author influential papers in professional journals to drive new direction to positively impact patients. (8) build coalitions and partnerships with other nonprofits in collaboratively driving and funding research projects for greater impact and scale because we are much more effective together than working alone. Skc prioritizes the delivery of transformative, next-generation Cancer therapies to this population that includes immunotherapy {vaccines, cellular therapy, oncolytic virotherapy, therapeutic antibodies, checkpoint inhibitors}, synergistic combination treatments, new genomically targeted drugs, interventional radiology techniques and novel delivery mechanisms. Our criteria for identifying and supporting these novel approaches aims to provide more effective and less toxic treatment options than the current standard-of-care. (9) we are planning a new initiative for medulloblastoma to identify promising combination therapies that cross the blood-brain barrier as well as new delivery mechanisms.

Grants made by Solving Kids Cancer

GranteeGrant descriptionAmount
The Children's Hospital of Philadelphia (CHOP)Cancer Research$322,793
National Cancer Center (NCC)Cancer Research$100,000
Boston Children's HospitalCancer Research$46,941

Who funds Solving Kids Cancer

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Ronan Thompson FoundationTo Fund A Clinical Trial for Targeted Therapies To Treat Neuroblastoma.$100,000
Band of ParentsCharitable$90,000
Fidelity Investments Charitable Gift FundFor Grant Recipient's Exempt Purposes$80,600
...and 16 more grants received

Personnel at Solving Kids Cancer

NameTitleCompensation
Scott KennedyExecutive Director$139,094
Kristi McKayDirector of Administration
Donna LudwinskiDirector , Research Programs and Partnerships
Eyal SofferTreasurer$0
Channing StaveSecretary$0
...and 1 more key personnel

Financials for Solving Kids Cancer

RevenuesFYE 12/2022
Total grants, contributions, etc.$970,445
Program services$0
Investment income and dividends$25,663
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$-101,841
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$894,267

Form 990s for Solving Kids Cancer

Fiscal year endingDate received by IRSFormPDF link
2022-122023-11-13990View PDF
2021-122022-11-14990View PDF
2020-122021-11-05990View PDF
2019-122021-02-19990View PDF
2018-122020-01-13990View PDF
...and 10 more Form 990s
Data update history
January 24, 2024
Updated personnel
Identified 1 new personnel
January 23, 2024
Posted financials
Added Form 990 for fiscal year 2022
January 3, 2024
Used new vendors
Identified 1 new vendor, including
December 25, 2023
Received grants
Identified 5 new grant, including a grant for $100,000 from Ronan Thompson Foundation
August 21, 2023
Received grants
Identified 1 new grant, including a grant for $15,000 from The Feinberg Family Foundation
Nonprofit Types
Grantmaking organizationsDisease research fundraisersDisease-focused nonprofitsCharities
Issues
HealthDiseases and disordersCancer
Characteristics
Provides grantsConducts researchFundraising eventsTax deductible donations
General information
Address
1 E 53rd St 8th Floor
New York, NY 10022
Metro area
New York-Newark-Jersey City, NY-NJ-PA
County
New York County, NY
Website URL
solvingkidscancer.org/ 
Phone
(212) 588-6624
IRS details
EIN
20-8735688
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2006
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
G30: Cancer
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
Free account sign-up

Want updates when Solving Kids Cancer has new information, or want to find more organizations like Solving Kids Cancer?

Create free Cause IQ account